Clinical Trial Search Results

  • CRD3003 - IMUNITI
    Keywords: CNTO1275CRD3003: A phase 3, randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the safety and efficacy of Ustekinumab maintenance therapy in subjects with moderately to severely active crohn's disease.
    Specialties: Gastroenterology, Irritable Bowel Syndrome,
    Status: Active, not recruiting Principal Investigator: Kathryn Peterson